¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Unqualified visual loss, both eyes"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® visual acuity ÇÑ±Û ½Ã·Â
¼³¸í   
  ´«À» °¡Áö°í Á¤È®È÷ º¸¾Æ ½Äº°ÇÒ ¼ö Àִ ´É·ÂÀÌ´Ù. ½Ã·ÂÇ¥¸¦ ÀÌ¿ëÇÏ¿© ÃøÁ¤ÇÑ´Ù. 5m¹Û¿¡¼­ ½Ã·ÂÇ¥¸¦ º¸¾Æ 2/3ÀÌ»ó ÀÐÀ» ¼ö Àִ ÃÖ´ë½Ã·ÂÀ» ½Ã·ÂÀ¸·Î Á¤ÇÑ´Ù. Á¤È®ÇÑ ½Ã·Â°Ë»ç´Â »êµ¿Á¦¸¦ Åõ¿©ÇÏ¿© ´«ÀÇ Á¶ÀýÀ» ¸·°í, °Ë¾È°æÀ¸·Î °Ë»çÇØ¾ß ÇÑ´Ù.
¿µ¹® visual field test ÇÑ±Û ½Ã¾ß°Ë»ç
¼³¸í   
  ´«À» ÇѰ÷¿¡ °íÁ¤½ÃŲ Ã¤, °üÂûÇÒ ¼ö Àִ ÁÖº¯°ø°£À» ½Ã¾ß¶ó ÇÑ´Ù. ½Ã¾ß¸¦ °Ë»çÇϴ °¡Àå °£´ÜÇÑ ¹æ¹ýÀº ´ë¸é°Ë»ç(confronting test)ÀÌ´Ù. À̰ÍÀº Çǰ˻çÀÚÀÇ ´«À» °Ë»çÀÚÀÇ ´«¿¡ ¸ÂÃ߾¸µµ·Ï ÇÏ¿© ´«À» °íÁ¤½ÃŲä, °Ë»çÀÚ°¡ ¼Õ°¡¶ô³¡À» À§ÂÊ, ¾Æ·¡ÂÊ, ¿ÞÂÊ, ¿À¸¥ÂÊ, ±×¸®°í ºñ½ºµëÈ÷ °æ»çÁø °÷ µîÀ¸·Î ¿Å°Üº¸¾Æ Çǰ˻çÀÚ°¡ °üÂûÇÒ ¼ö ÀÖ´ÂÁö ¿©ºÎ¸¦ Á¤Çϴ °Ë»ç¹ýÀÌ´Ù. À̺¸´Ù Á¤È®ÇÑ °Ë»ç¹ýÀº ÀÚµ¿½Ä ÄÄÇ»Åͽþ߰˻ç¹ýÀÌ ÀÖ´Ù. ´ë°³, ´«ÀÚüÀÇ ÀÌ»óÀÌ À־ ½Ã¾ß°Ë»ç¿¡¼­ ÀÌ»óÀÌ ³ª¿ÀÁö¸¸, À̿ܠ³úÀÇ ÀÌ»óÀ¸·Î ½Ã°¢ÀÇ Çü¼º°æ·Î¿¡ ÀÌ»óÀÌ À־ ¿ª½Ã ÀÌ»ó¼Ò°ßÀ» º¸ÀδÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • both eye blindness
    µÎ´«½Ã°¢»ó½Ç, ¾ç¾È½Ç¸í
  • organic visual loss
    ±âÁú½Ã°¢»ó½Ç
  • audiometric hearing loss
    û·Â¼Ò½Ç
  • abrasion loss
    ¸¶¸ê·®, ¸¶¸ð·®
  • allowable blood loss
    Çã¿ë½ÇÇ÷·®, Çã¿ëÇ÷¾×»ó½Ç·®
  • blood loss
    ½ÇÇ÷, Ç÷¾×»ó½Ç
  • conductive hearing loss
    ÀüÀ½³­Ã», Àüµµ³­Ã»
  • congenital hereditary hearing loss
    ¼±ÃµÀ¯Àü³­Ã»
  • cell loss
    ¼¼Æ÷¼Ò½Ç
  • central hearing loss
    ÁßÃßû·Â¼Ò½Ç, ÁßÃß³­Ã»
  • functional hearing loss
    ±â´É³­Ã»
  • familial progressive hearing loss
    °¡Á·¼ºÁøÇ೭û
  • hearing loss
    ³­Ã», û·Â¼Ò½Ç, û·ÂÀå¾Ö
  • heat loss
    ¿­¼Õ½Ç
  • high velocity signal loss
    °í¼Ó½ÅÈ£¼Ò½Ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • both eye blindness
    µÎ´«½Ã°¢»ó½Ç
  • loss
    »ó½Ç
  • abrasion loss
    ¸¶¸ê·®, ¸¶¸ð·®
  • blood loss
    ½ÇÇ÷, Ç÷¾×»ó½Ç
  • signal loss
    ½ÅÈ£¼Ò½Ç
  • loss of short-term variability
    ´Ü±âº¯µ¿¼Ò½Ç
  • binocular visual acuity
    ¾ç¾È½Ã·Â, µÎ´«½Ã·Â
  • visual acuity
    ½Ã·Â
  • visual cortex
    ½Ã°¢°ÑÁú, ½Ã°¢ÇÇÁú
  • visual disturbance
    ½Ã·ÂÀå¾Ö, ½Ã°¢Àå¾Ö
  • visual field defect
    ½Ã¾ß°á¼Õ
  • visual field
    ½Ã¾ß
  • visual hallucination
    ȯ½Ã
  • visual inspection
    ½ÃÁø
  • visual memory
    ½Ã°¢±â¾ï
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • organic visual loss
    ±âÁú½Ã°¢»ó½Ç
  • abrasion loss
    ¸¶¸ê·®, ¸¶¸ð·®
  • allowable blood loss
    Çã¿ë½ÇÇ÷·®
  • audiometric hearing loss
    û·Â¼Ò½Ç
  • blood loss
    ½ÇÇ÷, Ç÷¾×»ó½Ç
  • cell loss
    ¼¼Æ÷¼Ò½Ç
  • central hearing loss
    ÁßÃßû·Â¼Ò½Ç, ÁßÃß³­Ã»
  • condensed milk conductive hearing loss
    ³óÃà¿ìÀ¯ÀüµµÃ»°¢¼Ò½Ç
  • conductive hearing loss
    Àüµµ³­Ã»
  • conductive hearing loss
    ÀüÀ½¼º³­Ã»
  • congenital hereditary hearing loss
    ¼±ÃµÀ¯Àü³­Ã»
  • familial progressive hearing loss
    °¡Á·ÁøÇ೭û
  • functional hearing loss
    ±â´É³­Ã»
  • hearing loss
    ³­Ã», û·Â¼Ò½Ç
  • heat loss
    ¿­¼Õ½Ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • VIU=>visual internal urethrotomy
    ³»½Ã°æÀû ³»¿äµµ Àý°³¼ú
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • hallucination, visual
    ȯ½Ã(ü³ãÊ)
  • red green visual substance
    Àû·Ï(»ö)½Ã°¢ ¹°Áú.
  • Heat loss
    ¿­¼Õ½Ç(æðáßã÷)
  • NIHL [=noise induced hearing loss]
    ¼ÒÀ½¼º ³­Ã»
  • abrasion loss
    ¸¶¸ê·®(¸¶¸ê¾ç).
  • functional hearing loss
    ±â´É(¼º) ³­Ã»
  • hearing loss
    °¨°¢½Å°æ(¼º) ³­Ã»
  • hearing loss
    ³­Ã», û·Â¼Ò½Ç, û·ÂÀå¾Ö
  • hearing loss, audiometric
    û·Â¼Õ½Ç
  • hearing loss, central
    ÁßÃß¼º û·Â¼Ò½Ç, ÁßÃß¼º ³­Ã»
  • hearing loss, conductive
    ÀüÀ½¼º ³­Ã», Àüµµ¼º ³­Ã»
  • hearing loss, congenital hereditary
    ¼±Ãµ(¼º) À¯Àü¼º ³­Ã»
  • hearing loss, familial pregressive
    °¡Á· ÁøÇà(¼º) ³­Ã»
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • raccon eyes
  • organic visual loss
    ±âÁú½Ã°¢»ó½Ç
  • visual loss
    ½Ã°¢»ó½Ç, ½Ç¸í
  • abrasion loss
    ¸¶¸ê·®(¸¶¸ê¾ç).
  • audiometric hearing loss
    û·Â¼Õ½Ç
  • autoimmune disease,t-supperssor function loss
    T-¾ïÁ¦¼¼Æ÷ ±â´É»ó½Ç(¡­åäð¤á¬øàѦÒößÃã÷)
  • blood loss
    ½ÇÇ÷
  • blood loss
    ½ÇÇ÷(ã÷úì).
  • blood loss
    ½ÇÇ÷(½ÇÇ÷).
  • blood loss
    ½ÇÇ÷(ã÷úì)
  • blood loss
    ½ÇÇ÷(ã÷úì)
  • cell loss
    ¼¼Æ÷¼Ò½Ç
  • cell loss factor
    ¼¼Æ÷¼Ò½Ç°è¼ö
  • central hearing loss
    ÁßÃß¼º û·Â¼Ò½Ç, ÁßÃß¼º ³­Ã»
  • central hearing loss
    ÁßÃß¼º û·Â»ó½Ç, ÁßÃß¼º ³­Ã».
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • VISUAL ORGAN
    ½Ã°¢±â°ü
    [¿¾ ¿ë¾î] ½Ã°¢±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • coincidence loss
    µ¿½Ã¼Õ½Ç(ÔÒãÁáßã÷)
  • counting loss
    "°èÃø ¼Õ½Ç(ͪö´áßã÷), (ÔÒ) coincidence loss"
  • visual cycle
    ½Ã°¢ÁÖ±â(ãÊÊÆñÎÑ¢)
  • visual pigment
    ½Ã»ö¼Ò(ãÊßäáÈ)
  • visual purple
    ½ÃÀÚÈ«(ãÊí¹ûõ)
  • visual threshold
    "½Ã°¢(ãÊÊÆ) ¹®ÅÎ, ½Ã°¢ ¿ªÄ¡(ãÊÊÆæ¶ö·)"
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • central hearing loss
    ÁßÃß¼º û·Â»ó½Ç, ÁßÃß¼º ³­Ã»
  • energy loss
    ¿¡³ÊÁö¼Õ½Ç
  • hearing loss
    û°¢¼Õ½Ç
  • high velocity signal loss
    °í¼Óµµ½ÅÈ£¼Ò½Ç
  • sensorineural hearing loss
    °¨°¢½Å°æ¼º³­Ã»
  • signal loss
    ½ÅÈ£¼Ò½Ç
  • visual
    ½Ã·ÂÀÇ, ½Ã°¢ÀÇ
  • visual acuity
    ½Ã·Â
  • visual center
    ½Ã°¢ÁßÃß
  • visual cortex
    ½Ã°¢ÇÇÁú
  • visual field defect
    ½Ã¾ß°á¼Õ
  • visual organ
    ½Ã°¢±â
  • visual window
    ½Ã¾ßâ
  • weight loss
    üÁß°¨¼Ò, °¨·®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
OU Oculus Uterque; Each Eyes, Both Eyes; µÎ´« ´Ù
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
IDA   1) Imino-Diacetic Acid
  2) Iron Deficiency Anemia
   &nb...
O2 both eyes; diatomic oxygen; molecular oxygen
ou both eyes together [Lat. oculi unitas]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EYA Eyes Absent
EC eyes closed
EO eyes open
Ahl Age-related hearing loss
ABL Alveolar bone loss
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • H54.3
    Unqualified visual loss, both eyes
    ¾ç¾ÈÀÇ ½Ã·Â»ó½Ç È®ÀÎÀÌ ºÒ¸íÈ®ÇÑ °æ¿ì
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • central visual acuity
    Á᫐ ½Ã·Â
  • developmental test of visual motor integration
    ½Ã°¢ ¿îµ¿ ÅëÇÕ ¹ß´Þ °Ë»ç
  • visual aberration
    ½Ã°¢ Àå¾Ö
  • visual agnosia
    ½Ã°¢ ½ÇÀÎ
    ¸Á¸·¿¡¼­ Èĵο±ÀÇ Áö°¢Àüµµ·Î´Â Á¤»óÀε¥ º» °ÍÀ» ÀνÄÇÏÁö ¸øÇÏ´Â »óÅÂ.
  • visual angle
    ±¤°¢, ½Ã°¢
  • visual area
    ½Ã°¢ ¿µ¿ª
    ½Ã°¢ Åõ»ç ¿µ¿ª. Èĵο±ÀÇ ¼±Á¶ ÇÇÁú, ¼±Á¶ ÁÖÀ§ ÇÇÁú.
  • visual axis
    ½ÃÃà
    ¾È±¸ÀÇ ±¤Çа迡 À־ °áÁ¡°ú Á᫐ ¿Í¸¦ ÀÕ´Â ¼±.
  • visual center
    ½Ã°¢ ÁßÃß
    ÁßÁֽŰæ°è¿¡¼­ ½Ã°¢¿¡ Á÷Á¢ °ü¿©ÇÏ´Â ½Å°æ¼¼Æ÷ Áý´ÜÀ» °¡¸£Å°³ª ¸Á¸·À» Æ÷ÇÔ½ÃŰÁö ¾Ê´Â °ÍÀÌ º¸ÅëÀÌ´Ù.
  • visual cortex
    °¡½ÃÀû ÇÇÁú
  • visual experience
    °¡½ÃÀû °æÇè
  • visual field defect
    ½Ã¾ß °á¼Õ
    ¸Á¸·¿¡¼­ ´ë³ú ÇÇÁú¿¡ À̸£´Â ½Ã°¢°èÀÇ Àå¾Ö·Î ÀÎÇÑ ½Ã¾ßÀÇ ÀÌ»ó.
  • visual field test
    ½Ã¾ß °Ë»ç
    ÁÖº¯ ½Ã¾ß¿¡ ´ëÇÑ °Ë»ç.
  • visual image
    °¡½ÃÀû ¿µ»ó
  • visual memory test
    ½Ã°¢ ±â¾ï °Ë»ç
  • visual organ
    ½Ã°¢±â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
functional visual loss An apparent loss of visual acuity or visual field with no substantiating physical signs; often due to a natural concern about visual loss combined with suggestibility and a fear of the worst; best treated with reassurance.
(05 Mar 2000)
conjugate deviation of the eyes Rotation of the eyes equally and simultaneously in the same direction, as occurs normally, a condition in which both eyes are turned to the same side as a result of either paralysis or muscular spasm.
(05 Mar 2000)
conjugate movement of eyes Rotation of the two eyes in the same direction.
See: version.
(05 Mar 2000)
crossed eyes <clinical sign> A deviation of the eye which the patient cannot overcome. The visual axes assume a position relative to each other different from that required by the physiological conditions. The various forms of strabismus are spoken of as tropias, their direction being indicated by the appropriate prefix, as cyclo tropia, esotropia, exotropia, hypertropia and hypotropia. Also called cast, heterotropia, manifest deviation and squint.
Origin: Gr. Strabismos = a squinting
(18 Nov 1997)
spectacle eyes A condition in rats caused by pantothenic acid deficiency, and possibly lack of inositol as well, in which a hairless ring of inflamed skin surrounds the eye's.
(05 Mar 2000)
nine-eyes <zoology> The lamprey.
Source: Websters Dictionary
(01 Mar 1998)
disconjugate movement of eyes Rotation of the two eyes in opposite directions, as in convergence or divergence.
(05 Mar 2000)
eyes, cataracts Clouding of the lens portion of the eye. Cataracts will affect most people if they live long enough. Symptoms include double or blurred vision and sensitivity to light and glare. Cataracts can be diagnosed when the doctor examines the eyes with a viewing instrument. The ideal treatment for cataracts is surgical implantation of a new lens. Sunglasses can help to prevent cataracts.
(12 Dec 1998)
eyes, glaucoma Disease (there is more than one type) characterised by increased pressure within the eye. Glaucoma can lead to blindness. Glaucoma is five times more likely to occur in Blacks than in Whites. Early detection of glaucoma is essential to the preservation of vision. Glaucoma can be treated with medications, laser or traditional surgery.
(12 Dec 1998)
alveolar bone loss The resorption of bone in the supporting structures of the maxilla or mandible as a result of periodontal disease.
(12 Dec 1998)
axon loss polyneuropathy A type of polyneuropathy in which axon degeneration is the sole/predominant feature; many aetiologies, particularly toxic and metabolic; on nerve conduction studies, affects amplitudes of the responses, but does not cause conduction slowing or block.
Synonym: axonal polyneuropathy.
(05 Mar 2000)
blood loss, surgical Loss of blood during surgery.
(12 Dec 1998)
Parallel Electron Energy Loss Spectroscopy <technique> Electron energy loss spectroscopy analyses the inelastically scattered electrons present in the beam after it has been transmitted through the sample. An electron energy loss spectrum typically consists of a monatomic decreasing background on which are superimposed a number of peaks. Each peak is characteristic of the scattering process that has occurred in the sample. The peaks can be used to obtain information about the chemical composition and electronic structure of the sample. Electron energy loss spectra are acquired typically in a magnetic sector spectrometer located under the camera chamber of the transmission electron microscope. Spatial resolution is typically limited by the minimum probe diameter of the microscope. Electron energy loss spectroscopy tends to be complimentary to EDS in that it can be used to analyse very thin samples of low Z materials.
Acronym: PEELS
(05 Aug 1998)
periodontal attachment loss Loss or destruction of periodontal tissue caused by periodontitis or other destructive periodontal diseases or by injury during instrumentation. Attachment refers to the periodontal ligament which attaches to the alveolar bone. It has been hypothesised that treatment of the underlying periodontal disease and the seeding of periodontal ligament cells enable the creating of new attachment.
(12 Dec 1998)
water loss, insensible Loss of water by diffusion through the skin and by evaporation from the respiratory tract. It is so called because we do not know that we are actually losing water at the time that it is leaving the body. (guyton, textbook of medical physiology, 8th ed, p274)
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • unqualified
    ¹«ÀÚ°ÝÀÇ
  • unqualified
    ÀÚ°ÝÀÌ ¾÷´Â;ÀûÀÓÀÌ ¾Æ´Ñ;Á¦ÇÑ ¾ø´Â;¹«Á¶°ÇÀÇ;¼øÀüÇÑ
  • crab's-eyes
    ÇØ¾È¼®(°ÔÀÇ ¹äÅë ¼ÓÀÇ °á¼®,ÀÇ·á¿ë)
  • googoo eyes
    Ã߯Ä
  • saucer eyes
    Àï¹Ý°°ÀÌ µÕ±Ù ´«
  • both
    ¾çÂÊÀÇ
  • both ~ and -
    ~ µµ - µµ (µÑ´Ù)
  • make both ends meet
    ¼öÁö¸¦ ¸ÂÃß´Ù
  • both
    µÑ´Ù;½Ö¹æÀÇ;µÑ´ÙÀÇ;´Ù°°ÀÌ
  • be at a loss
    ºÒÈ®½ÇÇÑ »óÅ¿¡ ÀÖ´Ù
  • loss
    ºÐ½Ç
  • consequential loss insurance
    °£Á¢ ¼ÕÇØ º¸Çè
  • dead loss
    Àü¼Õ
  • friction loss
    ¸¶Âû¼Õ½Ç
  • loss
    ¼Õ½Ç;»ó½Ç;¼ÕÇØ;½ÇÆÐ;ÆÐ¹è;¼Ò¸ð;at a ~ °ï¶õÇÏ¿©;¾î¿ ÁÙ ¸ô¶ó¼­
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á